TradeFlare's AI research teams analysed NKE on 10 market nights between April 23, 2026 and October 8, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| October 8, 2026 | HOLD | $34.36 | — / — | not yet | not yet | The current market regime and stock-specific factors do not support a directional trade. |
| October 7, 2026 | HOLD | $34.61 | — / — | not yet | not yet | The current market regime and NKE's fundamental and technical outlook do not support a directional trade. |
| October 6, 2026 | HOLD | $33.96 | — / — | +2.1% | not yet | The current market and stock conditions do not support a directional trade. |
| October 5, 2026 | HOLD | $33.87 | — / — | +4.1% | not yet | The current market regime and NKE's fundamental and technical outlook do not support a buy decision. |
| October 2, 2026 | HOLD | $35.15 | — / — | +2.5% | not yet | The current market and NKE's fundamental and technical outlook do not support a buy recommendation. |
| July 3, 2026 | BUY | $44.09 | — / — | +1.0% | -1.6% | Post-earnings drift (PEAD) signal from a significant EPS beat. |
| July 2, 2026 | BUY | $43.06 | — / — | +0.6% | -5.4% | Post-earnings drift (PEAD) signal from a significant EPS beat. |
| July 1, 2026 | BUY | $41.05 | — / — | -0.7% | -1.8% | Post-earnings drift (PEAD) signal from a significant EPS beat. |
| April 27, 2026 | BUY | $44.69 | — / — | -4.5% | -0.4% | No clear bullish catalyst identified in the current market regime. |
| April 23, 2026 | BUY | $45.68 | — / — | -0.9% | -0.9% | Continued positive insider buying signals. |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.